Stanley-Laman Group’s Arrowhead Research ARWR Stock Holding History

Stanley-Laman Group’s Portfolio ARWR Stock Details ARWR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,429	Closed	-$342K	–	229
2022 Q4	$342K	Buy	+8,429	New	+$279K	0.07%	176
2022 Q1	–	Sell	-3,153	Closed	-$209K	–	277
2021 Q4	$209K	Buy	+3,153	New	+$217K	0.02%	253

Other funds holding ARWR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

RCMU

Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Stanley-Laman Group's ARWR Position: Q1 2023 in Review

Stanley-Laman Group sold out of Arrowhead Research (ARWR) in Q1 2023, closing a stake of 8,429 shares — an estimated $342K sold.

Stanley-Laman Group first reported a position in ARWR in Q4 2021 and held it in 2 quarters. The position peaked at $342K in Q4 2022. 256 funds tracked by Wall St. Rank hold ARWR as of Q1 2023.

Stanley-Laman Group reported no remaining Arrowhead Research position as of Q1 2023 after selling out during the quarter.
Stanley-Laman Group sold 8,429 Arrowhead Research shares in Q1 2023, an estimated $342K.
Stanley-Laman Group first reported a position in Arrowhead Research in Q4 2021 and held it in 2 quarters.
Stanley-Laman Group's Arrowhead Research position peaked at $342K in Q4 2022.
256 funds tracked by Wall St. Rank held Arrowhead Research as of Q1 2023.

Based on Stanley-Laman Group's 13F filing for Q1 2023, filed 18 Apr 2023.